Skip to main content

Table 2 Correlation of IBC and DCIS expression of ER, PR, and HER2 in mutation carriers with IBC with concurrent DCIS, stratified by BRCA mutation

From: DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3

IBC ER intensity

BRCA1

BRCA2

DCIS ER intensity

DCIS ER intensity

0

1

2

3

P value*

0

1

2

3

P value*

0

23

0

2

1

<0.001

4

1

0

0

<0.001

1

1

0

0

0

 

0

0

0

0

 

2

0

0

1

3

 

0

0

4

3

 

3

0

0

0

2

 

0

0

1

8

 

IBC PR intensity

DCIS PR intensity

DCIS PR intensity

0

1

2

3

P value*

0

1

2

3

P value*

0

23

0

3

2

<0.001

5

0

0

0

0.003

1

0

0

0

0

 

0

0

1

1

 

2

0

0

0

1

 

0

0

2

2

 

3

0

0

0

4

 

0

1

1

1

 

IBC HER2 intensity

DCIS HER2 intensity

DCIS HER2 intensity

0

1

2

3

P value*

0

1

2

3

P value*

 

16

5

0

0

0.46

7

5

0

0

<0.001

6

4

0

0

 

1

6

0

0

 

2

1

0

0

 

0

1

0

0

 
 

0

0

0

0

 

0

0

0

2

 
  1. * Linear trend test for a table with ordered rows and columns